期刊文献+

高危人群踝臂指数影响因素的多元回归分析 被引量:12

Multiple regression analysis of ankle-brachial index risk factors in high-risk population with peripheral arterial disease
暂未订购
导出
摘要 目的探讨影响外周动脉病(PAD)高危人群的踝臂指数(ABI)的重要危险因素。方法选取心内科、内分泌科等住院患者为研究对象,对851例PAD易患者测定ABI,并收集相关影响因素的资料,进行多元线性回归分析。结果851例高危人群中,242例ABI异常,PAD患病率为28.44%(242/851例),平均ABI为0.74±0.14。其中影响ABI的危险因素有性别(男性)、年龄、吸烟年数、脑血管意外史、心肌梗死史、高脂血症史、血脂水平以及服用利尿剂、降糖药物史等。结论ABI值受多种因素综合影响。 Objective To appraise the risk factors of ankle-braehial index(ABI) in high-risk population with peripheral arterial disease(PAD). Methods Selecting 851 hospitalized patients from departments of cardiology and endocrinology underment measurement of ABI, and collection of disease history together with drug use, serum and physical examinations. Multiple linear regression model was used to analyze the data. Results 242 among 851 high risk cases whose ABI≤0.9, the prevalence of PAD was 28.44% with the mean ABI as 0.74 ±0.14 in PAD patients. Gender (male), age, smoking, history of stroke, history of myocardial infraction, dyslipidemia, hypertension and diabetes were the risk factors of PAD. Conclusions ABI value is affected by multiple risk factors. (Shanghai Med J, 2006,29:4-6)
出处 《上海医学》 CAS CSCD 北大核心 2006年第1期4-6,共3页 Shanghai Medical Journal
关键词 踝臂指数 外周动脉病 危险因素 多元回归分析 Ankle-braehial index Peripheral arterial disease Risk faetor Multiple regression
  • 相关文献

参考文献12

  • 1Papamichael CM,Lekakis JP,Stamatelopoulos KS,et al.Ankle-brachial Index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease.Am J Cardiol,2000,86:615-618.
  • 2Sikkink CJ,van Asten WN,van't Hof MA,et al.Decreased ankle-brachial indices in relation to morbidity and mortality in patients with peripheral arterial disease.Vasc Med,1997,2:169-173.
  • 3Duprez D.Hope brings hope for the use of ankle-brachial index as cardiovascular risk marker.Eur Heart J,2004,25:1-2.
  • 4McDermott MM,Greenland P,Liu K,et al.The ankle brachial index is associated with leg function and physical activity:The Walking and Leg Circulation Study.Ann Intern Med,2002,136:873-883.
  • 5Ostergren J,Sleight P,Dagenais G,et al.Impact of rampril in patients with evidence of clinical or subclinical peripheral arterial disease.Eur Heart J,2004,25:17-24.
  • 6Criqui M H,Langer RD,Fronek A,et al.Mortality over a period of 10 years in patients with peripheral arterial disease.N Engl J Med,1992,326:381-386.
  • 7Dormandy JA,Rutherford RB.Management of peripheral arterial disease(PAD).TransAtlantic Inter-Society Consensus(TASC) Working Group.J Vasc Surg,2000,31:S1-S296.
  • 8Hertzer NR.Clinical experience with preoperative coronary angiography.J Vasc Surg,1985,2:510-514.
  • 9Criqui MH,Fronek A,Barrett-Connor E,et al.The prevalence of peripheral arterial disease in a defined population.Circulation,1985,71:510-515.
  • 10Mohler ER.Peripheral arterial disease:identification and implications.Arch Intern Med,2003,163:2306-2314.

同被引文献92

引证文献12

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部